The fair value estimate for Advanced Enzyme Technologies stays at ₹370.0, with analysts deciding not to shift the price target despite refreshed model inputs. Supportive voices see this as ...

The fair value estimate for Advanced Enzyme Technologies has been kept steady at ₹370.0 per share, with no change in the headline price target despite refreshed model inputs. Bullish and bearish ...

LOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a ...

Ethiopia stands out as a singular presence in East Africa, a nation where deep-rooted culinary traditions and distinctive local ingredients continue to shape the country’s food systems and milling ...

Stronger regulation and advanced recycling technologies will be critical to addressing the Australia's growing textile waste problem.

Exozymes are advanced enzymes enhanced through bioengineering and AI to thrive in a bioreactor without using living cells. Exozymes can replace toxic petrochemical processes and inefficient ...

Co-led by AP Ventures and FH One Investments, with participation from Talis Capital, CMPC Ventures, H&M Group, Understorey ...

Washington Research Foundation (WRF) has awarded a $7 million grant to the University of Washington Institute for Protein Design (IPD) to a ...

The therapy shows efficacy in improving diarrhea, abdominal pain in GLP-1, GLP-1/GIP-treated patients with diabetes and/or obesity in a small study.

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Givaudan Active Beauty proudly introduces VectorHyal™, a skin delivery system engineered to unlock the full potential of active cosmetic ingredients. Based on hyaluronic acid (H ...